A client with hypertension and benign prostate hyperplasia is prescribed doxazosin (Cardura). Which of the following statements below would the nurse emphasize regarding doxazosin (Cardura)?

A. Daily weight monitoring is not specifically indicated for doxazosin, and significant weight loss is typically not a primary concern with this medication. B. Doxazosin can cause first-dose hypotension, leading to dizziness; thus, the client should be advised to lie down after the initial dose to minimize this risk. C. Increasing potassium intake is not necessary with doxazosin; there are no direct interactions that would warrant dietary changes regarding potassium. D. Impaired taste is not a commonly reported side effect of doxazosin; this statement is misleading and not relevant to the medication's profile.